Discover Tenders by Non Decaffeinated Coffee Sector

Find the most relevant tenders for Non Decaffeinated Coffee. Access the latest tender notices from various government and private organizations published across hundreds of websites and newspapers.Obtain complete and accurate information on Non Decaffeinated Coffee tenders, including all tender documents, RFPs, RFQs,and more. Utilize our advanced filters to search for Non Decaffeinated Coffee tenders by organization, tender value, opening and closing dates, and more.

Filter Your Search

Country

Sector

Region

Funding Agency

Conclusion Of A Non Exclusive Discount Agreement According To Section 130A Paragraph 8 Sgb V For Medicinal Products Containing The Active Ingredient Combination Of Lopinavir And Ritonavir Atc Code J05Ar10

Deadline: 28 Jul 2026

Germany

Ref. No.: 7766088

EMD:Ref Document

Bid Value: Ref Document

314 Days Left

Conclusion Of A Non Exclusive Discount Agreement According To Section 130A Paragraph 8 Sgb V For Medicinal Products Containing The Active Ingredient Telmisartan Atc Code C09Ca07

Deadline: 28 Jul 2026

Germany

Ref. No.: 7747295

EMD:Ref Document

Bid Value: Ref Document

314 Days Left

Silicon Valley Innovation Program 5 Year Other Transaction Solicitation

Deadline: 20 May 2026

United States

Ref. No.: 7710547

EMD:Ref Document

Bid Value: Ref Document

245 Days Left

Open Framework Agreement On Pharmaceutical Discounts In Accordance With Section 130A Paragraph 8 Of The Social Code Book V With The Option To Join At Any Time So Called Approval Model 2024 02

Deadline: 05 Feb 2026

Germany

Ref. No.: 7708517

EMD:Ref Document

Bid Value: Ref Document

141 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Interferon Beta 1A L03Ab07 Subcutaneous Injection Within The Framework Of A So Call

Deadline: 31 Jul 2026

Germany

Ref. No.: 7708163

EMD:Ref Document

Bid Value: Ref Document

317 Days Left

Open Framework Agreement On Drug Discounts In Accordance With Section 130A Paragraph 8 Of The Social Code Book V With The Option To Join At Any Time So Called Approval Model 2024 05

Deadline: 05 May 2026

Germany

Ref. No.: 7708048

EMD:Ref Document

Bid Value: Ref Document

230 Days Left

Open Framework Agreement On Drug Discounts In Accordance With Section 130A Paragraph 8 Of The Social Code Book V With The Option To Join At Any Time So Called Approval Model 2024 07

Deadline: 05 Jul 2026

Germany

Ref. No.: 7706731

EMD:Ref Document

Bid Value: Ref Document

291 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Naproxen M01Ae02 Within The Framework Of A So Called Open House Model

Deadline: 31 Jul 2026

Germany

Ref. No.: 7702625

EMD:Ref Document

Bid Value: Ref Document

317 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Rasagiline N04Bd02 Within The Framework Of A So Called Open House Model

Deadline: 31 Jul 2026

Germany

Ref. No.: 7697176

EMD:Ref Document

Bid Value: Ref Document

317 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Miglustat A16Ax06 As Part Of A So Called Open House Model

Deadline: 31 Jul 2026

Germany

Ref. No.: 7696670

EMD:Ref Document

Bid Value: Ref Document

317 Days Left

Open Framework Agreement On Drug Discounts In Accordance With Section 130A Paragraph 8 Of The Social Code Book V With The Option To Join At Any Time So Called Approval Model 2024 08

Deadline: 05 Aug 2026

Germany

Ref. No.: 7696060

EMD:Ref Document

Bid Value: Ref Document

322 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Lacosamide N03Ax18 Excluding Film Coated Tablets Within The Framework Of A So Call

Deadline: 31 Jul 2026

Germany

Ref. No.: 7693028

EMD:Ref Document

Bid Value: Ref Document

317 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Febuxostat M04Aa03 As Part Of A So Called Open House Model

Deadline: 31 Jul 2026

Germany

Ref. No.: 7690242

EMD:Ref Document

Bid Value: Ref Document

317 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredients Irbesartan And Hydrochlorothiazide C09Da24 Within The Framework Of A So Called Open

Deadline: 31 Jul 2026

Germany

Ref. No.: 7682368

EMD:Ref Document

Bid Value: Ref Document

317 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredients Timolol And Latanoprost S01Ed61 Within The Framework Of A So Called Open House Mod

Deadline: 31 Jul 2026

Germany

Ref. No.: 7681822

EMD:Ref Document

Bid Value: Ref Document

317 Days Left

Showing 25651 to 25665 of 26205 results

‹
1
2
...
1708
1709
1710
1711
1712
1713
1714
...
1746
1747
›

Discover Tenders by Non Decaffeinated Coffee Sector

Filter Your Search

Tenders by Countries

Browse Popular Sectors

Projects by Regions

Funding Agency

Support

CONTACT DETAILS

Discover Tenders by Non Decaffeinated Coffee Sector

Filter Your Search

FREE Trial plan for all new users!